PHARMACOKINETICS OF CANA2EDTA AND CHELATION OF LEAD IN RENAL-FAILURE

被引：22

作者：

OSTERLOH, J

BECKER, CE

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1986年 / 40卷 / 06期

关键词：

D O I：

10.1038/clpt.1986.245

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：686 / 693

页数：8

共 40 条

[1]

AHLGREN L, 1980, BRIT J IND MED, V37, P109

[2] INDICATORS OF INTERNAL DOSE IN CURRENT AND PAST EXPOSURE TO LEAD [J].

ALESSIO, L ;

CASTOLDI, MR ;

MONELLI, O ;

TOFFOLETTO, F ;

ZOCCHETTI, C .

INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1979, 44 (02) :127-132

[3]

ARAKI S, 1982, BRIT J IND MED, V39, P157

[4]

ARAKI S., 1975, Ind. Hlth, V13, P179

[5] A COMPARISON OF THE DIMINUTION RATES OF LEAD IN BLOOD AND LEAD MOBILIZED BY CEDTA AFTER TERMINATION OF OCCUPATIONAL EXPOSURE - A LONG-TERM OBSERVATION IN 2 LEAD WORKERS [J].

ARAKI, S ;

MURATA, K ;

AONO, H ;

YANAGIHARA, S ;

USHIO, K .

JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1983, 20 (05) :475-486

[6] BEHAVIOR OF LEAD AND ZINC IN PLASMA, ERYTHROCYTES, AND URINE AND ALAD IN ERYTHROCYTES FOLLOWING INTRAVENOUS-INFUSION OF CAEDTA IN LEAD WORKERS [J].

ARAKI, S ;

AONO, H ;

FUKAHORI, M ;

TABUKI, K .

ARCHIVES OF ENVIRONMENTAL HEALTH, 1984, 39 (05) :363-367

[7] INTERACTION OF LEAD WITH ERYTHROCYTES [J].

BARLTROP, D ;

SMITH, A .

EXPERIENTIA, 1971, 27 (01) :92-&

[8] CONTRIBUTION OF LEAD TO HYPERTENSION WITH RENAL IMPAIRMENT [J].

BATUMAN, V ;

LANDY, E ;

MAESAKA, JK ;

WEDEEN, RP .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (01) :17-21

[9] THE ROLE OF LEAD IN GOUT NEPHROPATHY [J].

BATUMAN, V ;

MAESAKA, JK ;

HADDAD, B ;

TEPPER, E ;

LANDY, E ;

WEDEEN, RP .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) :520-523

[10]

BERMAN E, 1980, TOXIC METALS THEIR A, P130

← 1 2 3 4 →